Current Pediatric Reviews
Title:Meet Our Editorial Board Member
Volume: 12 Issue: 3
Author(s): Alan P. Knutsen
Affiliation:
Export Options
About this article
Cite this article as:
Knutsen P. Alan, Meet Our Editorial Board Member, Current Pediatric Reviews 2016; 12 (3) . https://dx.doi.org/10.2174/157339631203160908194903
DOI https://dx.doi.org/10.2174/157339631203160908194903 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
54
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Lipoic Acid: A Novel Therapeutic Approach for Multiple Sclerosis and Other Chronic Inflammatory Diseases of the CNS
Endocrine, Metabolic & Immune Disorders - Drug Targets Alpha 1 Anti-Trypsin: One Protein, Many Functions
Current Molecular Medicine Production of 68Ga-citrate Based on a SnO2 Generator for Short-Term Turpentine Oil-Induced Inflammation Imaging in Rats
Current Radiopharmaceuticals The Antioxidant Response Element and Oxidative Stress Modifiers in Airway Diseases
Current Molecular Medicine Chemokines and their Receptors in Gut Homeostasis and Disease
Current Immunology Reviews (Discontinued) Bilayer Tablet Based Chronotherapeutics in the Management of Nocturnal Asthma: An Overview
Recent Patents on Drug Delivery & Formulation Selected Engineering and Physicochemical Aspects of Systemic Drug Delivery by Inhalation
Current Pharmaceutical Design Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Camptothecins and Lung Cancer: Improved Delivery Systems by Aerosol
Current Cancer Drug Targets Therapeutic Strategies for Treatment of Inflammation-related Depression
Current Neuropharmacology Anti-inflammatory Potential of GSK-3 Inhibitors
Current Drug Targets Exploring N<sup>1</sup>-p-Fluorobenzyl-Cymserine as an Inhibitor of 5-Lipoxygenase as a Candidate for Type 2 Diabetes and Neurodegenerative Disorder Treatment
CNS & Neurological Disorders - Drug Targets Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol
CNS & Neurological Disorders - Drug Targets The Guinea Pig as an Animal Model for Asthma
Current Drug Targets Editorial
Current Pediatric Reviews Expression Levels of MicroRNA-125b in Serum Exosomes of Patients with Asthma of Different Severity and its Diagnostic Significance
Current Drug Metabolism Cytochrome P450 Drug Metabolizing Enzymes in Roma Population Samples: Systematic Review of the Literature
Current Medicinal Chemistry Effects of [Nphe1]nociceptin(1-13)NH2, [Phe1(CH2-NH)Gly2]nociceptin(1- 13)NH2, and Nocistatin on Nociceptin Inhibited Constrictions of Guinea Pig Isolated Bronchus
Protein & Peptide Letters Perioperative B-blockers in Non-cardiac Surgery: Actual Situation
Current Pharmaceutical Design CD28: A New Drug Target for Immune Disease
Current Drug Targets